Abstract

Introduction: Giant-cell granuloma (GCG) is a benign tumor occurring almost exclusively in the jaws. These lesions remain rare but can sometime have an aggressive behavior. In this article, we will describe and follow two cases of GCG. Observations: The first case is a referred female patient, who presents a mandibular swelling. Its clinical and radiological aspects lead us to do a biopsy, with a histological result of GCG. The second case is a patient with a terminal kidney failure, referred for a buccal swelling in the upper left jaw. The cone-beam computed tomography X-ray shows a compartmentalized lesion with blurry limits. An excisional biopsy is performed and the histological diagnosis is a GCG. Discussion: Although the first patient suffers from no systemic disease, the second one presents a terminal kidney failure resulting in a chronic hyperparathyroidism. Hyperparathyroidism can activate osteoclastic resorption and create bone lesions such as brown tumors. Conclusion: The slow and asymptomatic growth of these lesions often result in a late diagnosis. It should be kept in mind as a differential diagnosis when dealing with an osteolytic lesion of the jaws with no clear etiology, especially if hyperparathyroidism or kidney failure is associated.

Highlights

  • Giant-cell granuloma (GCG) belongs to a family of giant-cell tumors and pseudotumors. This group of polymorphic tumors includes aneurysmal bone cysts, cherubism, giant-cell tumors, and brown tumors caused by hyperparathyroidism [1,2]

  • We present two GCG cases along with a discussion regarding management of GCG and a related literature review

  • We presented two cases of GCG in two adult women

Read more

Summary

Introduction

Giant-cell granuloma (GCG) belongs to a family of giant-cell tumors and pseudotumors. In some cases, these lesions may become aggressive, which is an indication for modifying the clinical management (larger surgical margins, combination drug treatments). We noted a lacunar bone lesion and hypocalcemia associated with hyperparathyroidism, in the context of end-stage renal failure. Non-aggressive GCGs are minimally symptomatic or even asymptomatic, and they progress slowly and rarely relapse after surgical removal This was observed with both cases in presented this report. Its usage was studied in a randomized, double-blind, and placebo-controlled trial, in which the researchers reveal a significantly lower recurrence rate when treating GCG by aggressive surgical management followed by intranasal calcitonin [16]

Exeresis and histological analysis
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call